TNFRSF11B and Miyoshi myopathy: The increase in osteoclast activity observable in patients with MM is due to an imbalance between the receptor activator of nuclear factor kB (RANK) and osteoprotegerin (OPG), caused, in turn, by the increased production of RANK ligand (RANKL) and the decreased production of osteoprotegerin.